Administration of CORM-2 inhibits diabetic neuropathy but does not reduce dyslipidemia in diabetic mice.
Méndez-Lara KA, Santos D, Farré N, Ruiz-Nogales S, Leánez S, Sánchez-Quesada JL, Zapico E, Lerma E, Escolà-Gil JC, Blanco-Vaca F, Martín-Campos JM, Julve J, Pol O.
Méndez-Lara KA, et al. Among authors: zapico e.
PLoS One. 2018 Oct 4;13(10):e0204841. doi: 10.1371/journal.pone.0204841. eCollection 2018.
PLoS One. 2018.
PMID: 30286142
Free PMC article.